solifenacin succinate 10 mg

1 INDICATIONS AND USAGE Solifenacin succinate tablets are indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Solifenacin succinate tablets are a muscarinic antagonist indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. (1)

Aurobindo Pharma Limited

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] off label use` `[3] fatigue` `[4] nausea` `[5] pain` `[6] headache` `[7] dyspnoea` `[8] diarrhoea` `[9] pyrexia` `[10] arthralgia`

1 year ago

ROUND PINK CC 32

1 year ago

CC 32 ROUND PINK

16 HOW SUPPLIED/STORAGE AND HANDLING

SOLIFENACIN SUCCINATE Tablets 5 mg are light yellow colored, round shaped, biconvex, film-coated tablets debossed with ‘CC’ on one side and ‘31’ on the other side. Bottles of 30 NDC 65862-878-30 Bottles of 90 NDC 65862-878-90 Bottles of 1,000 NDC 65862-878-99 3 x 10 Unit-dose Tablets NDC 65862-878-03

SOLIFENACIN SUCCINATE Tablets 10 mg are light pink colored, round shaped, biconvex, film-coated tablets debossed with ‘CC’ on one side and ‘32’ on the other side. Bottles of 30 NDC 65862-879-30 Bottles of 90 NDC 65862-879-90 Bottles of 1,000 NDC 65862-879-99 3 x 10 Unit-dose Tablets NDC 65862-879-03 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].

More pills like ROUND CC 32

Related Pills

solifenacin succinate 5 mg

Aurobindo Pharma Limited

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site